An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)
Clinical trial NCT01161836 · COMPLETED
Trial details
- NCT number
- NCT01161836
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-02-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.